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Inductive interactions mediated by interplay
of asymmetric signalling underlie development
of adult haematopoietic stem cells
Ce´line Souilhol1, Christe`le Gonneau1, Javier G. Lendinez1, Antoniana Batsivari1, Stanislav Rybtsov1,
Heather Wilson1, Lucia Morgado-Palacin1, David Hills1, Samir Taoudi2,3,4, Jennifer Antonchuk5, Suling Zhao1
& Alexander Medvinsky1
During embryonic development, adult haematopoietic stem cells (HSCs) emerge
preferentially in the ventral domain of the aorta in the aorta–gonad–mesonephros (AGM)
region. Several signalling pathways such as Notch, Wnt, Shh and RA are implicated in this
process, yet how these interact to regulate the emergence of HSCs has not previously been
described in mammals. Using a combination of ex vivo and in vivo approaches, we report here
that stage-speciﬁc reciprocal dorso–ventral inductive interactions and lateral input from the
urogenital ridges are required to drive HSC development in the aorta. Our study strongly
suggests that these inductive interactions in the AGM region are mediated by the interplay
between spatially polarized signalling pathways. Speciﬁcally, Shh produced in the dorsal
region of the AGM, stem cell factor in the ventral and lateral regions, and BMP inhibitory
signals in the ventral tissue are integral parts of the regulatory system involved in the
development of HSCs.
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H
aematopoietic stem cells (HSCs) lie at the foundation of
the adult haematopoietic system, and give rise to cells
of all blood lineages throughout the lifespan of
an organism. An important property of adult (deﬁnitive)
haematopoietic stem cells (dHSCs) is that they are capable of
long-term reconstitution of the haematopoietic system upon
transplantation into irradiated recipients. In the mouse, such cells
develop by embryonic stages E10–E11 in the aorta–gonad–
mesonephros (AGM) region1–4. An ex vivo approach showed that
the AGM region has a robust autonomous capacity to generate
dHSCs1. The AGM region comprises the dorsal aorta ﬂanked on
both sides by the urogenital ridges (UGRs), which contain
embryonic rudiments of kidney and mesonephros. HSCs develop
in a polarized manner, predominantly in the ventral ﬂoor of the
dorsal aorta (AoV), more rarely in the dorsal domain of the
dorsal aorta (AoD), and are absent in the UGRs2,5–7. Localization
of dHSCs to the AoV in mouse and human embryos was shown
by long-term reconstitution experiments5,6.
Abundant evidence indicates that during development, a
specialized embryonic endothelial compartment known as haema-
togenic (or haemogenic) endothelium gives rise to haematopoietic
stem and progenitors cells7–10. The haematopoietic programme in
various vertebrate models is executed predominantly in the AoV,
and is recognized by the expression of essential haematopoietic
transcription factors, for example, Runx1 and cKit, and the
appearance of clusters of haematopoietic cells budding from the
endothelium of the dorsal aorta6,8,9,11–14.
It is broadly accepted that HSCs develop from the
haematogenic endothelium within intra-aortic clusters. This
transition involves several consecutive maturation steps of HSC
precursors: pro-HSCs-pre-HSC type I-pre-HSC type II-
dHSC15–17. All these precursors express endothelial markers,
such as vascular-endothelial cadherin (VC) and CD31, and
sequentially upregulate haematopoietic surface markers: CD41
(pro-HSCs), CD43 (pre-HSC type I) and ﬁnally CD45 (pre-HSC
type II). This maturation process occurs in the dorsal aorta
between E9 and E11. Speciﬁcally, pro-HSCs emerge at E9,
pre-HSCs Type I appear at E10 and pre-HSCs type II
predominantly at E11. Unlike dHSCs, pre-HSCs cannot
reconstitute the adult haematopoietic system by direct
transplantation and require prior maturation in an embryonic
or neonatal environment15–19.
A number of signalling pathways (Notch, Wnt, retinoic acid,
interleukin-3 and inﬂammatory) have been implicated in HSC
development; however, a coherent picture is yet to be
elucidated15,17,20–31. HSC precursors (pro-HSCs, pre-HSCs type
I and pre-HSCs type II) express cKit17 from early developmental
stages. A recent study has shown that the cKit ligand, known as
stem cell factor (SCF), is a key regulator driving maturation of
these HSC precursors into dHSCs in the AGM region17, which is
in agreement with the marked decline of HSC activity in
SCF mutant mice32,33. In the adult, SCF is critically important
for HSC maintenance in the bone marrow niche, mainly in
the endothelial compartment32. Sonic Hedgehog (Shh) and bone
morphogenetic protein 4 (BMP4) pathways are also important
mediators; in zebraﬁsh, these two morphogenes are involved in
arterial speciﬁcation and haematopoietic patterning,
respectively34,35. In the mouse, subaortic BMP4 and Shh/Indian
Hedgehog derived from gut were also proposed to be responsible
for HSC development36,37.
During development, interactions between spatially segregated
compartments are essential for tissue patterning and speciﬁcation,
and are often mediated by gradients of secreted molecules38–40.
Molecules secreted by distant tissues, such as somites, can
inﬂuence HSC development in the AGM region41–45. Developing
HSCs are embedded in the complex AGM microenvironment,
suggesting that HSC development may require signals derived
from different compartments of the AGM region. We sought to
test this hypothesis. However, the analysis of HSC development
in vivo is signiﬁcantly hampered by low accessibility of embryos
developing in utero, fast maturation of dHSCs, lack of uniquely
speciﬁc markers for HSC precursors and their low numbers in the
AGM region. Therefore, we employed here a robust ex vivo
culture system that models HSC development in the embryo
in combination with functional HSC analysis using in vivo
long-term reconstitution assay15–17. Speciﬁcally, to study
interactions between AGM subregions, we took advantage of
the in vitro reaggregation system that enables close juxtaposition
of cell types15.
We show that interactions between three compartments of the
AGM, the AoV, the AoD and the UGRs, are necessary for
efﬁcient generation of dHSCs. First, we show that dHSC activity
in the isolated E10.5 AoV is limited but can be signiﬁcantly
enhanced by co-culture with the AoD, and that this is mediated at
least partly by Shh, secreted dorsally in vivo. Second, while HSC
activity in isolated E11.5 AoD is limited, co-culture with a
competent AoV microenvironment activates dHSC generation in
the AoD. We found that this effect is mediated by SCF, which is
secreted abundantly by the AoV stroma in vivo as shown here.
Third, we show that downregulation of BMP4 signalling by BMP
antagonist Noggin, which is present at high levels in the AoV and
especially in intra-aortic clusters as revealed here by in vivo
observations, is required for HSC development. Fourth, UGRs,
which express high levels of SCF, also enhance HSC development
in the dorsal aorta.
Our results based on in vivo observations and ex vivo
modelling strongly suggest that juxtaposed, anatomically distinct
domains within the AGM region create a complex landscape of
interactive signals that underpins HSC development.
Results
Pre-HSCs localize preferentially to the AoV. As dHSCs mature
from pre-HSCs, we investigated whether the emergence of dHSC
predominantly in the AoV6 is a result of asymmetric (ventralized)
distribution of pre-HSCs. Dorsal aortae were separated from
UGRs and bisected into AoV and AoD (including notochord) as
described previously6 (Supplementary Fig. 1a). The different
domains were then directly transplanted into irradiated mice to
detect dHSCs. We ﬁrst conﬁrmed our previous observation that
at E11.5 dHSCs appear almost exclusively in the AoV, although
some dHSCs were in the AoD and engrafted few recipients at
high level (Supplementary Fig. 1b). Limiting dilution analysis
showed that dHSCs are approximately four times more frequent
in the AoV compared with AoD. UGRs did not contain HSCs in
line with previous reports2,6.
We then investigated the spatial distribution of pre-HSCs
type I and pre-HSCs type II in E10.5–E11.5 embryos using the
OP9 co-culture system supplemented with Il3þ SCFþ Flt3
(termed 3GF), which allows pre-HSCs (which do not engraft by
direct transplantation) to mature into dHSC that become
detectable by long-term repopulation assay as described
previously16. Doses of transplanted cells (expressed in embryo
equivalents, e.e.) were chosen based on the requirements of
individual experiments (explained in Methods section). In these
experiments (Fig. 1), the dose injected was high (1–2 e.e.) to
detect potentially low dHSC numbers in AoD and UGRs.
We have shown previously that E10.5 AGM region mainly
contains type I pre-HSCs, whereas at E11.5, type I and type II
pre-HSCs co-exist16. Dissected E10.5 AGM regions co-cultured
with OP9 in 3GF for 5 days were transplanted into adult
irradiated recipients. Out of 21 recipients that received cultured
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AoV, 20 showed high levels (470%) of donor-derived long-term
haematopoietic chimerism (Fig. 1a). In contrast, only 7 out of 16
recipients of cultured AoD were repopulated at high levels
(470%), while the remaining recipients showed lower or no
repopulation (7 and 2, respectively). Cultured UGRs did not
produce dHSCs (Fig. 1a). Thus, we conclude that the E10.5 AoD
does contain pre-HSCs but at signiﬁcantly lower numbers than
the AoV.
We then investigated whether pre-HSCs localization changes
in E11.5 embryos and found that pre-HSCs were still exclusively
localized to the dorsal aorta; UGRs carefully separated from the
lateral mesenchyme adjacent to the dorsal aorta did not give any
repopulation after culture (Fig. 1b). To establish the location of
pre-HSCs within the E11.5 dorsal aorta, cell populations
enriched for pre-HSCs type I (VCþCD45-) and pre-HSCs type
II (VCþCD45þ ) were sorted from AoV and AoD, and
co-cultured with OP9 stromal cells in the presence of 3GF as
described previously16. We again were able to detect pre-HSC
activity in AoD although at lower levels than in AoV. After
maturation ex vivo, pre-HSCs type I from AoV and AoD
repopulated 7 of 11 and 2 of 8 recipients, respectively (Fig. 1c).
Similarly, cultured pre-HSCs type II from AoV and AoD
repopulated 11 out of 12 and 4 out of 10 recipients,
respectively (Fig. 1d). In all cases, multilineage engraftment was
conﬁrmed (Supplementary Fig. 2). These data show that pre-
HSCs are signiﬁcantly enriched in AoV.
Reciprocal inductive interactions between AoD and AoV. To
explore hypothetical interactions between AoD and AoV, we made
use of a dissociation–reaggregation system that recapitulates HSC
development ex vivo15. This system allowed us to integrate AGM
domains in a three-dimensional tissue-like organoid15 and study
their interactions in HSC development. To track the origin of
dHSCs, AoV and AoD from wild-type (WT) and green ﬂuorescent
protein (GFP) embryos with constitutive expression of GFP46 were
co-aggregated (termed AoV//AoD co-aggregates) and cultured for
5 days in the presence of 3GF before transplantation (Fig. 2a). Mice
transplanted with AoV//AoD co-aggregates can be reconstituted
by dHSCs coming from AoD and AoV. The presence of GFP
allowed the individual contributions of AoV and AoD to the total
repopulation level within the same mouse to be assessed (Fig. 2b,c).
This is presented in two separate columns in the graph. Namely,
while columns 1 and 3 represent the same recipient mice,
the former shows exclusively the contribution of the AoD and
the latter shows exclusively the contribution of the AoV into each
recipient. To assess the inﬂuence of AoD and AoV interaction on
HSC development, the repopulation by co-aggregated AoD
(column 1) or AoV (column 3) can then be compared with
repopulation by independently cultured AoD (column 2) or AoV
(column 4). All experiments included reciprocal use of WT and
GFP tissues in AoV//AoD co-aggregates, and we observed no
difference in repopulation properties between WT and GFP
embryos. Homotypic AoV//AoV and AoD//AoD co-aggregates
were always used as controls. Note that in these experiments, only
0.2 e.e. were injected per recipient, to ensure that the repopulation
levels were not saturated and to allow any inductive effects to be
revealed.
Using this approach, we found that the E10.5 AoV generates
more dHSCs when combined with AoD than on its own (Fig. 2b,
compare two rightmost columns). One day later, E11.5 AoD had
no positive inﬂuence on dHSC generation by AoV (Fig. 2c,
compare two rightmost columns). Conversely, the E11.5 AoD
produced more HSCs when reaggregated with the AoV than on its
own (Fig. 2c, compare two leftmost columns). This inductive effect
of AoV on AoD was not observed at E10.5 (Fig. 2b, compare two
leftmost columns). These ex vivo modelling experiments revealed
reciprocal stage-speciﬁc effects of AoV and AoD on HSC
development, which could be explained by the differential release
of factors by the two regions and/or by differences in the
competency of the target cells to respond to signals.
UGRs enhance HSC development in the dorsal aorta. UGRs do
not develop HSCs within their own microenvironment (Fig. 1a,b).
We tested whether the competent environment of the dorsal aorta
can induce dHSCs in UGRs. Chimeric WT//GFP co-aggregates of
E11.5 aortas and UGRs were cultured in the presence of 3GF, and
then transplanted into irradiated mice (Fig. 2a). Mice injected
with these reaggregates could be repopulated with dHSCs coming
from the aortas and/or UGRs. The presence of GFP allowed the
contributions of aortas and UGRs to the total repopulation level
in the recipient mice to be assessed and these are presented in the
two separate columns (Fig. 2d). Long-term haematopoietic
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Figure 1 | Localization of pre-HSCs in the AGM region. (a) E10.5 AoV, AoD and UGRs were co-aggregated with OP9 and cultured for 5 days, and the
formation of dHSCs was then tested by transplantation into irradiated mice (2 e.e. per recipient; AoV: six independent experiments; AoD: four independent
experiments; UGRs: two independent experiments). Dashed line indicates the cutoff for high-level engraftment (470% donor chimaerism). (b) E11.5 aortas
and UGRs were transplanted after reaggregate culture (Ao: 0.2 e.e. per recipient and UGRs: 1 e.e. per recipient; two independent experiments). (c,d) Pre-HSCs
type I (VCþCD45 ) (c) or type II (VCþCD45þ ) (d) sorted from E11.5 AoV and AoD were co-aggregated with OP9 cells and transplanted after
culture (1 e.e. per recipient; two independent experiments). (a–d) Levels of engraftment are plotted, and number of repopulated versus total number of
transplanted mice are shown in brackets. Number of embryo equivalents (ee) injected in each experiment are indicated on the graphs. (*Po0.05;
***Po0.005; Mann–Whitney U-test). In all these experiments, tissues were cultured with three growth factors (Flt3I, Il3 and SCF). AGM, aorta–gonad–
mesonephros region; Ao, dorsal Aorta; AoV, ventral domain of the dorsal aorta; AoD, dorsal domain of the dorsal aorta; UGRs, urogenital ridges.
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repopulation originated exclusively from the dorsal aorta and not
from UGRs (Fig. 2d), demonstrating that the dorsal aorta cannot
induce dHSC generation in the UGRs. We then investigated
whether UGRs could induce dHSCs in the dorsal aorta. When
comparing aorta alone to aorta cultured with UGRs, we found
that the presence of UGRs signiﬁcantly enhanced HSC develop-
ment in the dorsal aorta (Fig. 2e). This positive effect of UGRs
was observed for both AoD and AoV at E10.5 and E11.5
(Supplementary Fig. 3).
SCF expression is involved in polarized HSC development. The
results described above could be explained by the differential
production of factors by the AoD, AoV and UGRs. We
have recently shown that SCF is a potent inducer of early HSC
precursors in an ex vivo system17. Quantitative reverse
transcription-PCR (qRT–PCR) showed that SCF expression in
the AGM region is polarized, exhibiting higher levels in AoV and
UGRs compared with the AoD (Fig. 3a). Clear segregation
between the dorsal and ventral compartments of the AGM region
can be readily visualized by enhanced expression of SCF in the
AoV and UGRs using SCF-GFP knock-in mice32 (Fig. 3b)
or direct detection of SCF protein (Supplementary Fig. 4). Both
non-endothelial stroma and endothelial cells expressed SCF at
high levels, but the former showed clear dorso–ventral
polarization in SCF expression (Fig. 3c). Importantly, we found
that the pre-HSC type I population also expressed SCF,
suggesting that a positive-autocrine loop may be involved in
their development (Fig. 3c).
We then tested whether SCF can induce dHSC formation in
the AoD. Addition of soluble SCF efﬁciently induced dHSC
generation from E10.5 and E11.5 AoD explants (Fig. 3d,e).
SCF could also enhance dHSC generation by AoV (Fig. 3f).
Conversely, recombinant soluble SCF receptor (SCF-Rh), which
binds SCF with high afﬁnity and blocks activation of the cKit
receptor, signiﬁcantly reduced the number of repopulated mice
transplanted with AoD cultures compared with SCF-treated or
untreated control explants (Fig. 3d).
Shh signalling enhances dHSC generation. Since dissected AoD
tissue includes the notochord, it is likely to be a rich source of
Shh47. We conﬁrmed this by qRT–PCR (Fig. 4a) and by analysis of
GBS (Gli-binding site)-GFP48 reporter mice for Hh pathway
activity (Supplementary Fig. 5). A signiﬁcantly higher level of Hh
activity was observed in the AoD compared with the AoV tissue
(Supplementary Fig. 5). We therefore tested whether Shh could be
responsible for the positive impact of AoD on AoV-derived dHSCs.
Indeed, addition of recombinant Shh protein to cultures lacking
exogenous cytokines signiﬁcantly increased HSC development in
E10.5 AoV (Fig. 4c). Similarly, a Shh doxycycline-inducible OP9
cell line (doxOP9-Shh; Supplementary Fig. 6) co-aggregated with
E10.5 AoV cells, also increased HSC development from AoV after
doxycycline induction and this was abrogated in the presence of an
Hh antagonist (Fig. 4d). The explant and co-aggregation analyses
above suggest that the inductive effect of AoD on AoV observed at
E10.5 is at least partly mediated by Shh.
At E11.5, addition of Shh could no longer induce HSC
development in AoV (Fig. 4f), which is in line with the more
subtle effect of AoD on AoV at this stage (Fig. 2c). In keeping
with this result, addition of the Hh antagonist inhibited HSC
development in the E10.5, but not in the E11.5 AGM region
(Fig. 4e,g). Notably, qRT–PCR analysis revealed signiﬁcant
expression levels of Patched1 (Hh receptor) and Gli1 (Hh target)
in pre-HSCs type I, but almost no expression of these genes in
pre-HSC type II (Fig. 4b). These data suggest that Shh signalling
acts speciﬁcally on pre-HSCs type I and, as E10.5 AGM contains
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Figure 2 | Inductive interactions between AoV, AoD and UGRs as
revealed by an ex vivo model system. (a) Experimental design: the ventral
domain (AoV) and the dorsal domain (AoD) of the aorta, and the urogenital
ridges (UGRs) from wild-type (WT) and GFPþ embryos were subdissected,
and chimeric reaggregates from tissues of these two genotypes were generated.
Left column: to test interactions between AoV and AoD, chimeric AoV//AoD
reaggregates were generated and transplanted into irradiated recipients after 4–
5 days of culture (b,c). Right column: to test interactions between Ao and
UGRs, chimeric Ao//UGR reaggregates were generated and transplanted into
irradiated recipients after 4–5 days culture (d). GFPþ and/or GFP donor-
derived long-term repopulation allowed us to conclude whether dHSCs
originated from AoV, AoD or UGRs. Accordingly, the tissue of origin of donor
dHSCs is indicated below each graph. (b) E10.5 aortas from WT and GFP
embryos were used to generate chimeric reaggregates as depicted
schematically above plots. The reciprocal combination of WT and GFP tissues
was used to generate AoV//AoD reaggregates. The tissue source of dHSCs is
shown separately in the leftmost (AoD) and rightmost (AoV) columns as
indicated below the plot (0.2e.e. per recipient; two independent experiments).
(c) E11.5 aortas from WT and GFP embryos were used to generate chimeric
reaggregates. The tissue source of dHSCs is shown separately in the leftmost
(AoD) and rightmost (AoV) columns as indicated below the plot (0.2e.e. per
recipient; two independent experiments). (d) E11.5 aortas (Ao) and UGRs from
WTand GFP embryos were used to generate Ao//UGR chimeric reaggregates.
As depicted schematically above the plot, the reciprocal combination of WTand
GFP tissues was used to generate Ao//UGR reaggregates. The tissue source of
dHSCs is shown separately in left (Ao) and right (UGRs) columns as indicated
below the plot (0.01 e.e. per recipient; six independent experiments).
(e) Reaggregation of WT Ao with UGRs generate more dHSCs than Ao alone
(0.05e.e. per recipient; two independent experiments). (b–e) In all these
experiments, tissues were cultured with three growth factors.
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almost exclusively pre-HSCs type I (ref. 16), they provide an
explanation for the stage-speciﬁc effect of Shh.
Why are dHSCs absent in the Shh-rich AoD in vivo? We found
that expression of Patched1 and Gli1 is considerably lower in
pre-HSC type I derived from the AoD compared with AoV
(Fig. 4b), suggesting their reduced sensitivity to Shh. Accordingly,
the stimulatory effect of Shh on AoD explants was insigniﬁcant
compared with its effect on AoV explants (Fig. 4c). Low
sensitivity of dorsally localized pre-HSC type I to Shh may be
responsible for attenuated maturation of HSCs in AoD in vivo.
BMP signalling is downregulated in the dHSC lineage. The
emergence of dHSCs in the AoV has been previously attributed to
ventrally localized BMP signalling 34,36,49. As expected, qRT–PCR
showed that BMP4 is expressed at higher levels in the AoV
compared with the AoD (Fig. 5a). Accordingly, BMP4 and
phosphorylated forms of Smad1,5,8 (P-Smad), indicative of active
Bmp signalling50, were abundant in the ventral subaortic
mesenchyme (Fig. 5b,c,e–g; Supplementary Fig. 7).
However, when we analysed BMP targets genes (Id1, Id2 and
Id3) in cell populations directly isolated from the embryo, we
found that Id genes are highly expressed in endothelial cells and
pre-HSCs type I, but their expression is signiﬁcantly lower in
pre-HSC type II (Fig. 5d), suggesting a decrease of BMP activity
between pre-HSC type I and type II stage. Accordingly, at
the morphological level, P-Smad is highly expressed in some
luminal aortic endothelial (CD31þCD45 ) cells and at the base
of intra-aortic haematopoietic clusters (Fig. 5e–g; Supplementary
Fig. 7). Within the clusters, P-Smad levels were lower in CD31þ
CD45 /low cells (Fig. 5e,g, green arrows) and further reduced in
cells localized at the periphery of the cluster that acquired CD45,
which, together with CD31, deﬁnes the pre-HSC type II
phenotype (Fig. 5e–g, white arrowheads; Supplementary Fig. 8).
Taken together, our data suggest that BMP activity is
downregulated during progression of the HSC lineage in vivo
(Fig. 6e).
How can high BMP4 levels in the AoV be reconciled with the
downregulation of BMP activity in the HSC lineage? qRT–PCR
showed that BMP antagonists such as Noggin, Chordin and
Chordin-like2 are expressed at high levels in the AoV in vivo
(Fig. 6a). Indicatively, inhibitory Smad6 and Smad7 are also
expressed at higher levels in AoV, compared with AoD (Fig. 6a).
Furthermore, immunostaining experiments conﬁrm the
preferential expression of Noggin in the ventral domain of the
AGM (Fig. 6b). Thus, BMP antagonists may be responsible for
downregulation of BMP signalling in developing HSCs.
Confocal analysis showed that BMP4 is mainly expressed in
subendothelial mesenchyme and is barely detectable in
intra-aortic clusters in vivo (Figs 5b and 6c; Supplementary
Fig. 9a). By contrast, although Noggin is also expressed in
subendothelial mesenchyme (Fig. 6b), its expression is readily
observed in haematopoietic clusters (Fig. 6c; Supplementary
Fig. 9b). Accordingly, qRT–PCR analysis showed that Noggin
is highly expressed in the ventral mesenchyme and at lower
but signiﬁcant levels in pre-HSCs type I (Fig. 6d). Thus,
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downregulation of BMP signalling in the developing HSC lineage
observed in vivo can be explained by exposure to high levels of
Noggin and a low concentration of BMP4 in intra-aortic clusters
(Fig. 6e).
BMP signalling inhibits HSC development. To assess the impact
of BMP signalling on HSC generation, we used AGM cultures
supplemented with BMP4 and assessed dHSC production by the
long-term transplantation assay. As the fetal calf serum contains
BMP4 (ref. 51), we used a serum-free culture system and
demonstrated a consistent dose-dependent inhibitory effect of
BMP4 on HSC development in E10.5–E11.5 AGM cultures with
concomitant increase in the expression of BMP target genes
(Fig. 7a–c; Supplementary Fig. 10a).
By contrast, addition of Noggin (Z100 ngml 1), in the
presence or absence of serum, considerably enhanced production
of dHSCs in AoV explants and decreased the expression of BMP
target genes (Fig. 7d; Supplementary Figs 10b and 11). Notably,
Noggin could also induce HSC development in AoD explants in
the presence and particularly in the absence of serum (Fig. 7d;
Supplementary Fig. 11). These results suggest that efﬁcient
HSC development requires that BMP signalling in the AGM
region is kept at relatively low levels.
Interactions between SCF, Shh and BMP signalling pathways.
The above studies indicate that HSC development in the AGM
region is orchestrated in a complex signalling environment
consisting of overlapping gradients of SCF, Shh and BMP.
We tested whether these signalling pathways can inﬂuence
each other. We obtained no conclusive data to suggest that
addition of Shh/BMP4 modulates SCF expression and vice versa
(Supplementary Fig. 12). However, supplementation of AGM
cultures with Shh resulted in consistent upregulation of Noggin
and Smad6 (Fig. 8a). Noggin in turn enhanced Shh expression,
thus creating a positive-feedback loop supporting maturation of
HSCs (Fig. 8b). Conversely, BMP4 reduced Shh and Ptch1
expression (Fig. 8b). These results obtained using ex vivo
modelling system indicate that spatially polarized Shh, SCF and
BMP signalling in the AGM region are integral parts of an
epistatic regulatory system that drives HSC development in the
AGM region in vivo (Fig. 8c).
Discussion
We have shown previously that during murine embryo
development deﬁnitive HSCs emerge predominantly in the
ventral domain of the dorsal aorta (AoV)6. This spatially
polarized production of HSCs might be explained by different
origins of dorsal and ventral endothelium and/or by asymmetric
production of key factors involved in HSC development37,52,53
and we reasoned that directional inductive interactions between
AGM compartments could be involved. Great insight into
inductive interactions in various organs has previously been
obtained through in vitro modelling39. Here we modelled
interactions between AGM domains in a co-culture system,
which supports HSC development15. Using this ex vivo system,
we demonstrate that at early stages (E10.5) HSC maturation in
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the AoV region is enhanced by the presence of the AoD. One day
later (E11.5), the AoV microenvironment is able to induce HSC
development in the AoD, previously thought to be mostly devoid
of HSC activity6. We also found that UGRs can enhance HSC
production from the dorsal aorta, but cannot generate dHSCs
themselves, even under inﬂuence of the dorsal aorta. Thus, our
data strongly suggest that reciprocal stage-speciﬁc inductive
AoD//AoV interactions and involvement of UGRs are required
for execution of the robust development of HSCs in vivo.
Our data indicate that previously established dorso–ventrally
polarized HSC development6 is deﬁned by two main factors. First,
our current data show that although the AoD contains pre-HSCs
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(both type I and type II), their numbers are lower than in AoV, in
line with lower intra-aortic cluster formation previously described
in mouse AoD6,13. Second, as shown here, dHSCs can be induced
in the AoD by the AoV, and therefore the dHSCs
deﬁciency in AoD cannot be explained solely by asymmetric
pre-HSC distribution, but may also be inﬂuenced by differences
in the microenvironment.
To study this, we focused on SCF, Shh and BMP4, whose
expressions are dorso–ventrally polarized in the AGM
region36,47,49 (and current data). We found that SCF is an
inductive signal that is expressed at high levels in the AoV and
UGRs, and can stimulate HSC development in isolated AoD, a
region which had previously been considered to be mostly devoid
of HSC activity. This is in agreement with a key role of SCF in
HSC maturation17. We found that the aortic endothelial
compartment expresses high levels of SCF, suggesting its
important role in HSC development comparable to the bone
marrow microenvironment of adult HSCs32. Importantly, we
found that the pre-HSC type I population expresses SCF
suggesting a positive-autocrine loop, which could promote HSC
development.
Shh signalling in zebraﬁsh is required for aortic angioblast
migration and subsequent arterial speciﬁcation of the dorsal
aorta34,54. We found that in mouse Shh stimulates and a Hh
antagonist inhibits the development of HSCs at E10.5 but not at
E11.5, in keeping with a previous study37. The induction of
dHSCs in AoV by AoD is also limited to the E10.5 stage.
Since Shh is secreted by the notochord (which is included in
AoD-dissected tissue), this stage speciﬁcity is likely deﬁned by the
predominant presence of pre-HSCs type I at E10.5, which express
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higher levels of Shh signalling components (Ptch1 and Gli1)
compared with pre-HSCs type II. By E11.5, the pre-HSC
population is mainly represented by type II cells15.
Stage-speciﬁc loss of sensitivity to Hh signalling was also
described in the developing neural tube55. Notably, the poor
ability of AoD to develop HSCs despite abundant presence of Shh
can also be explained by lower levels of Ptch1 and Gli1 detected in
AoD- compared with AoV-derived pre-HSC type I. Our ex vivo
modelling data indicate that AoD-derived Shh is an active
inducer of HSC development in the AGM region. This conclusion
does not exclude the possibility that Shh secreted by the gut could
also reach the dorsal aorta37, although by E10.5 these sites are
separated by an extended mesentery.
BMP4 signalling is a key factor involved during differentiation
of ventral mesoderm and its further speciﬁcation into haemato-
poietic cells. In zebraﬁsh, BMP signalling is clearly required
during the patterning of the dorsal aorta and for the emergence of
dHSCs in the ventral wall34. Its role in mouse is less clear due to
the early lethality of BMP mutants56. Several lines of evidence
point to BMP4 as a good candidate regulating HSC development.
Indeed, BMP4 is highly expressed in the ventral mesenchyme
underneath the dorsal aorta34,36,49; some reports suggested its
role in controlling dHSC emergence36,57,58. However, the in vitro
systems used likely assayed the maintenance of dHSCs, rather
than their maturation. It was also reported that BMP4 signalling
can deﬁne their differentiation potential59. BMP4 is also involved
in the regulation of essential haematopoietic transcription factors
such as Scl/Gata2/Fli1 and Runx1 (refs 60,61). Here we analysed
BMP signalling activity in the dHSC lineage in the AGM region.
We show that in vivo the pre-HSC type I to type II transition is
accompanied by a downregulation of BMP targets (Id genes).
This correlates with our data demonstrating that BMP activity is
downregulated in intra-aortic clusters and the observations of
others that Runx1 expression is attenuating in the developing
HSC lineage60,62,63. How is this decrease of BMP activity achieved
in vivo, despite the presence of BMP4 in AoV? It has previously
been noted that in amphibian embryos several BMP inhibitors are
also expressed in AoV34. Similarly, our analysis of the embryo
showed high expression of a number of BMP antagonists as well
as inhibitory Smad6 and Smad7 in mouse AoV that may
counteract BMP4 action in HSC lineage. Furthermore, we found
that in the AGM region BMP4 and Noggin are spatially
segregated: Noggin being present in haematopoietic clusters and
BMP4 being mainly expressed underneath the aortic
endothelium. Therefore, maturing HSCs in clusters are exposed
to low BMP4 concentration and high concentration of the BMP
antagonist Noggin. Furthermore, our qRT–PCR analysis shows
that the pre-HSC type I population expresses Noggin, which
possibly creates a very effective shield that protects them from
BMP4. Accordingly, our ex vivo analysis strongly suggests that
downregulation of BMP signalling is functionally important for
HSC development in the embryo. Indeed, forced BMP signalling
activation by the addition of BMP4, strongly inhibits HSC
development, and conversely the addition of Noggin stimulates
HSC development in E10.5–E11.5 AGM cultures. These results
are in line with recent observation that deletion of Smad4, a
common transducer for BMP4/TGFb signalling, markedly
augments the formation of intra-aortic clusters64. Our data do
not exclude the possibility that BMP4 is essential for speciﬁcation
of mouse dHSCs at earlier stages, as described in the zebraﬁsh
model, where BMP signalling is required for HSC development at
stages closer to mouse E8.5 (ref. 34).
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Our analysis indicates that all three signalling pathways studied
can cooperate for HSC development (Fig. 8c). Notably, the
interplay of Shh and BMP pathways is broadly involved in
development. For example, counter gradients of polarized Shh
and BMP signalling in the developing spinal cord specify
neuronal subsets along the dorso–ventral axis65, and the
dorsal aorta resembles the neural tube with inverse orientation
of Shh- and BMP-secreting centres34. However, we detected an
antagonistic relationship between Shh and BMP pathways. At the
molecular level, Shh can induce Noggin and Smad6 expression,
thus inhibiting BMP4 signalling. In turn, BMP4 suppresses and,
accordingly, Noggin enhances Shh signalling. Cooperation
between Shh and Noggin has been previously described as
critically important for developmental speciﬁcation of somitic,
neural and hair follicle cells66–68. Our in vitro data suggest that
the feed-forward loop Shh-Noggin/Noggin-Shh is also
involved in HSC development in vivo.
We propose a model where the polarized secreted factors form
complex ﬁelds of gradients in vivo, which deﬁne an effector zone
for optimal HSC development in the dorsal aorta and lead to the
ventrally shifted appearance of dHSCs (Fig. 8c). Of interest,
intra-aortic clusters are abundant in ventro–lateral positions69,
which may reﬂect the position of this zone. The dissection close
to such a zone could lead to accidental inclusion of powerful
dHSCs in AoD samples observed here. Furthermore, it is possible
that spatial segregation of co-operating and spatial overlap of
antagonizing factors may also be important for adjustment of
HSC development in vivo. Indeed, although the pool of pre-HSCs
in the AGM region markedly expands during E9.5–11.5 (Rybtsov
et al., submitted), complete maturation of the HSC pool is
limited: while the majority of cells reach the pre-HSC type II
stage, only one or two dHSCs are generated by the end of E11.
Such controlled dynamics of HSC development may be needed to
prevent a burst of active haematopoiesis in the AGM region. How
exactly HSC maturation dynamics depend on overlapping
concentrations of factors requires further analysis. Although
ex vivo modelling is a powerful tool to dissect mechanisms of
HSC development in vivo, there will likely be some variation in
details. For example, spatial polarization in the developing HSC
niche may deﬁne kinetics of HSC development in vivo. While we
have demonstrated spatial polarization in vivo of the factors
driving HSC development in our model system, it is currently
unclear whether any factors become expressed in a polarized
manner within the reaggregates and as such, whether polarization
is also a pre-requisite for HSC maturation. Alternatively, if
polarization is not required, the entire reaggregate may replicate
the optimal zone for HSC development, resulting in massive
generation of dHSCs. The distinction between these two scenarios
will require further investigation.
In summary, our ex vivo modelling experiments suggest that
HSC development in the embryo involves stage-dependent
interactions between dorsal, ventral and lateral domains of the
AGM region, mediated at least partly by the interplay of SCF,
Shh, BMP4 and Noggin. Further detailed analysis will be required
to better understand the complexity of the AGM signalling
landscape in which HSC development takes place. Such knowl-
edge may lead to development of novel protocols for the
generation of deﬁnitive HSCs in vitro for clinical applications.
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Methods
Mice. Mice were housed and bred in animal facilities at the University of
Edinburgh in compliance with the Home Ofﬁce regulations. Embryos for
experiments were obtained from C57BL/6 CD45.2/2, C57BL/6 GFP mice46, SCF-
GFP mice32 (gift from Sean J. Morrison) and GBS-GFP mice48 (gift from James
Briscoe). The day of discovery of the vaginal plug was designated as day 0.5. The
embryos were additionally staged based on somite pair numbers (E10.5¼ 35–38 sp,
E11.5¼ 41–45 sp). C57BL/6 CD45.1/2 females or males were used as recipient
mice and C57BL/6 CD45.1/1 as a source of carrier cells. All experiments with
animals were approved under a project license 60/3916 granted by the Home Ofﬁce
(UK), University of Edinburgh Ethical Review Committee, and conducted in
accordance with local guidelines.
Explant and reaggregate cultures. Isolated E10.5 and E11.5 AGM regions were
subdissected into AoV, AoD and UGRs. The notochord was included in the AoD.
AGM regions were either cultured as explants or dissociated by collagenase/dispase
and then either self-reaggregated or co-aggregated with OP9 stromal cells. For
self-reaggregation, AGM cell suspensions were centrifuged at 430g for 12mn in
200-ml pipette tips sealed with paraﬁlm to form a pullet. For co-aggregation with
OP9, cell suspension of 1 e.e. of AGM cells or 1 e.e. of sorted cells were mixed with
105 OP9 cells prior centrifugation. Cell aggregates or explants were cultured at
the liquid–gas interface on 0.8-mm nitrocellulose ﬁlters (Millipore) for 5 days
(37 C, 5% CO2) in 5ml of IMDM (Invitrogen), 20% fetal calf serum supplemented
with L-glutamine (4mM), penicillin/streptomycin (50Uml 1), and 100 ngml 1
SCF, 100 ngml 1 IL3 and 100 ngml 1 Flt3l (termed 3GF), unless otherwise
indicated (all purchased from Peprotech). For generation of chimeric reaggregate
cultures, AGM regions isolated from age-matched BL/6 WT and BL/6 GFP
embryos were subdissected into AoV, AoD and UGRs, and after cell dissociation
combined in reaggreates.
The different culture systems used in our study are listed in Supplementary
Table 1, as well as indications as to their efﬁciency in terms of HSC development.
Mouse recombinant proteins Bmp4, Noggin, Shh and human SCF receptor
were purchased from R&D Systems and the Hh antagonist was a gift from
Genentech (Dr Stephen Gould).
Transplantation assay. AGM tissues from C57BL/6 CD45.2/2 embryos were
pooled (unless otherwise stated) and cell suspensions obtained after dissociation
with collagenase/dispase (Roche) for 40min at 37 C. Donor cells were injected
intravenously into C57BL/6 CD45.1/2 sublethally irradiated (1,150 rad) mice along
with 20,000 C57BL/6 CD45.1/1 bone marrow carrier cells. The amount of trans-
planted cells is expressed in embryo equivalents, deﬁned as a unit of cells equivalent
to the number present in one organ. (for example, 0.2 e.e. corresponds to 20% of
cells present in one AGM region). The number of embryo equivalents injected for
each experiment was chosen based on the expected outcome of dHSC numbers,
which can vary for a given tissue depending on culture conditions. For example, the
use of different culture systems (co-aggregation with OP9 cells, self-reaggregation
or explants) in the presence or absence of cytokines gives different HSC outcomes.
Depending on the experimental question, we had to adjust the number of embryo
equivalents injected to detect a small number of dHSCs (high dose of cells injected)
or to avoid saturation of repopulation to allow assessment of inductive
factors/tissues (low dose of cells injected).
Long-term haematopoietic repopulation was assessed in peripheral blood
between 14 and 16 weeks after transplantation. Peripheral blood was collected by
bleeding the tail vein into 500 ml of 5mM EDTA/PBS, and erythrocytes were
depleted using PharM Lyse (BD). Cells were stained with anti-CD16/32 (Fc-block),
anti-CD45.1-APC (cloneA20) and anti-CD45.2-PE (clone 104) monoclonal
antibodies (eBioscience), and analysed using a FACSCalibur. Data were analysed
using the FlowJo software (TreeStar). Recipients of the chimeric reaggregates were
analysed for both CD45.2 and aGFP donor markers. Mice exhibiting 45% of
donor chimerism were considered to be repopulated with dHSCs. Different groups
of repopulated mice were compared using Mann–Whitney U statistical tests
(*Po0.05; **Po0.01; ***Po0.005).
Fluorescence-activated cell sorting. Single-cell suspensions from the AGM
region were prepared by dispase/collagenase-mediated dissociation. Antibodies
used for staining of cells were anti-CD45-BV450 (BD Horizon, clone 30F11, 1:100),
anti-CD45-AF700 (1:100, clone 30F11, BD pharmingen), anti-VE-cadherin-AF647
or -AF488 (1:100, Clone eBioBV13, Biolegend) and biotinylated anti-VE-Cadherin
(1:50, clone 11.D4.1, Pharmingen), followed by incubation with streptavidin-PE
(1:600, BD Pharmingen), anti-CD43-PE (1:200, clone eBioR2/60, eBioscience),
anti-cKit-APC (1:100, clone 2B8, eBioscience), anti-CD31-PE (1:200, MEC13.3,
Pharmingen), anti-Sca1-V500 (1:100, clone D7, BD Bioscience), anti-CD41-BV421
(1:100, clone MWreg30, Biolegend) and anti-Ter119-PerCp-Cy5.5 (1:100, clone
TER119, eBioscience). 7-Aminoactinomycin D viability staining solution was used
to exclude dead cells, and gates were set using appropriate ﬂuorescence minus one
controls. Sorting was performed on a FACSAriaII using the FACSDiva software.
Quantitative reverse transcription–PCR. Total RNA was isolated from AoV,
AoD, UGRs (using at least 4 e.e. of tissue for each sample) and OP9 with Qiagen
RNeasy microkit or minikit (Qiagen), and complementary (cDNA) was prepared
using SuperScriptVILO cDNA Synthesis (Invitrogen). The qRT–PCR was
performed using the LightCycler 480 SYBR Green I MasterMix (Roche). For gene
expression on a small number of cells, total RNA was isolated from 200 cells
directly FACS-sorted into a PCR tube containing 10 ml of  2 Reaction Mix
(CellsDirect, Invitrogen) and 0.2 ml RNase inhibitor (SUPERase-In Ambion
AM2694). cDNA preampliﬁcation of the genes of interest was achieved by adding
directly Superscript III/Taq mix (CellsDirect) and primers (10 mM each) to the cell
lysate (PCR programme: 50 C for 15min; 95 C for 2min; 18 cycles of: 95 C for
15 s; 60 C for 4min). A universal probe library strategy with Lightcycler 480
probes mastermix kit (Roche) was used to perform qRT–PCR on these samples.
Duplicate reactions were set-up with diluted preampliﬁed cDNA. PCR primers
were designed using the Roche software. All experiments were performed in
biological duplicates or more. Expression values were normalized against the
TATA-binding protein, and standard error of the mean (s.e.m.) were calculated
and plotted using the Prism6 software (GraphPad). Primer sequences can be found
in Supplementary Table 2. The expression data are expressed as mean±s.e.m.
Statistical analysis were performed using Student’s t-tests. Signiﬁcance is indicated
in the ﬁgures with the following convention: (*Po0.05; **Po0.01; ***Po0.005).
Shh doxycycline-inducible OP9 cell line (doxOP9-Shh). cDNA coding for Shh
was cloned into pPBhCMV1-cHA-IRESVenuspA vector, a doxycycline-inducible
bicistronic expression vector—gift from H. Niwa70—allowing both Shh and Venus
to be expressed upon induction. OP9 cells (n¼ 100,000) were electroporated with
this plasmid using NEON transfecting system (Invitrogen). The next day, the
electroporated cells were cultured in the presence of 1 mgml 1 doxycycline
(Clontech). After 24 h of treatment, doxOP9-Shh cells expressing Venus were
sorted using FACSAriaII and plated in culture without doxycycline. After 1 week in
culture, a second sort was performed to remove any cells constitutively expressing
Venus. Before co-aggregation with AGM cells, doxOP9-Shh cells were cultured for
24 h in regular growth medium supplemented with 1 mgml 1 doxycycline.
Co-aggregates were cultured in the presence of doxycycline for 5 days. OP9 cells
were grown at 37 C in a humidiﬁed atmosphere (5% CO2). The growth medium
was IMDM (Invitrogen) supplemented with 20% fetal calf serum and penicillin/
streptomycin (50Uml 1).
Immunoﬂuorescence. Embryos were ﬁxed in 4% paraformaldehyde at 4 C
overnight (P-Smad staining) or for 45mn (BMP4 and Noggin stainings) and
embedded in OCT by ﬂash freezing on dry ice. Transverse sections (7 mM) were
produced using a CM1900 Crystat (Leica). Sections were permeabilized in
PBS/0.1% Triton/1% BSA for 1 h, before blocking for 30mn in PBS/10% fetal
calf heat-inactivated serum. Immunostainings were performed using rabbit
anti-P-Smad1,5,8 (1:100, clone D5B10, Cell Signaling Technology), goat
anti-BMP4 (1:50, clone N-16, Santa Cruz Biotechnology), goat anti-Noggin
(1:100, clone AF 719, R&D systems), rabbit anti-SCF (1:50, ab64677, Abcam),
unconjugated rat anti-CD31 or PE-conjugated anti-CD31 (1:50, MEC13.3,
Pharmingen), goat anti-CD45 (1:100, clone AF 114, R&D systems) and rat
anti-cKit (1:100, clone 2B8, Biolegend), followed by incubation with anti-goat
Alexa ﬂuor 488 (1:100, Invitrogen), anti-goat NL577 (1:100, R&D systems),
anti-rabbit Alexa ﬂuor 488 (1:100, Invitrogen) and anti-rat Alexa ﬂuor 647
(1:100, Invitrogen). Images were acquired with an inverted confocal microscope
(SP8) and processed using FiJi software.
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